UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Current vascular pharmacology, 2011-05, Vol.9 (3), p.258-270

2011

Volltextzugriff (PDF)

Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis

Current vascular pharmacology, 2011-05, Vol.9 (3), p.271-280

2011

Volltextzugriff (PDF)

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction

Hypertension (Dallas, Tex. 1979), 2012-05, Vol.59 (5), p.1069-1078

2012

Volltextzugriff (PDF)

Methods to study postprandial lipemia

Current vascular pharmacology, 2011-05, Vol.9 (3), p.302-308

2011

Volltextzugriff (PDF)

Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture

Clinical chemistry (Baltimore, Md.), 2011-10, Vol.57 (10), p.1415-1423

2011

Volltextzugriff (PDF)

The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response

The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3452-3460

2017

Volltextzugriff (PDF)

PCSK9 and triglyceride-rich lipoprotein metabolism

Journal of biomedical research, 2015-01, Vol.29 (6), p.429-436

2015

Volltextzugriff (PDF)

Effect of hemodialysis on extracellular vesicles and circulating submicron particles

BMC nephrology, 2019-08, Vol.20 (1), p.294-8, Article 294

2019

Volltextzugriff (PDF)

Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia

Annals of internal medicine, 2009-11, Vol.151 (9), p.622

2009

Volltextzugriff (PDF)

Proposing a "lipemic index" as a nutritional and research tool

Current vascular pharmacology, 2011-05, Vol.9 (3), p.313-317

2011

Volltextzugriff (PDF)

Transition of Patients with Type 2 Diabetes from Specialist to Primary Care: A Survey of Primary Care Physicians on the Usefulness of Tools for Transition

Canadian journal of diabetes, 2008, Vol.32 (1), p.37-45

2008

Volltextzugriff (PDF)

Using a Structured Discharge Letter Template to Improve Communication During the Transition from a Specialized Outpatient Diabetes Clinic to a Primary Care Physician

Canadian journal of diabetes, 2015-12, Vol.39 (6), p.457-466

2015

Volltextzugriff (PDF)

Postprandial lipaemia and vascular disease

Current opinion in cardiology, 2013-07, Vol.28 (4), p.446-451

2013

Volltextzugriff (PDF)

Patient Perspectives on Discharge from Specialist Type 2 Diabetes Care Back to Primary Care: A Qualitative Study

Canadian journal of diabetes, 2014-06, Vol.38 (3), p.191-197

2014

Volltextzugriff (PDF)

Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy

The Annals of pharmacotherapy, 2006-09, Vol.40 (9), p.1672-1676

2006

Volltextzugriff (PDF)

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

The New England journal of medicine, 2013-12, Vol.369 (26), p.2492-2503

2013

Volltextzugriff (PDF)

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors

The Journal of nutrition, 2017-04, Vol.147 (4), p.473-481

2017

Volltextzugriff (PDF)

Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function

The journal of clinical endocrinology and metabolism, 2018-09, Vol.103 (9), p.3486-3495

2018

Volltextzugriff (PDF)

Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood

ISRN endocrinology, 2013-06, Vol.2013, p.341632-8

2013

Volltextzugriff (PDF)

A11518 Hemodialysis reduces levels of circulating microparticles in individuals with hypertension

Journal of hypertension, 2018-10, Vol.36 Suppl 3, p.e202-e203

2018

Volltextzugriff (PDF)

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors12

The Journal of nutrition, 2017-04, Vol.147 (4), p.473-481

2017

Volltextzugriff (PDF)

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors

The Journal of nutrition, 2017-04, Vol.147 (4), p.471

2017

Volltextzugriff (PDF)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans

Lipids in health and disease, 2008-06, Vol.7 (1), p.22-22

2008

Volltextzugriff (PDF)

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations

Lipids in health and disease, 2013-05, Vol.12 (1), p.70-70, Article 70

2013

Volltextzugriff (PDF)

PCSK9 and triglyceride-rich lipoprotein metabolism

Journal of biomedical research, 2015-07, Vol.29 (6), p.429-436

2015

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(54)
Buchkapitel
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction

Methods to study postprandial lipemia

Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture

The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response

PCSK9 and triglyceride-rich lipoprotein metabolism

Effect of hemodialysis on extracellular vesicles and circulating submicron particles

Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia

Proposing a "lipemic index" as a nutritional and research tool

Transition of Patients with Type 2 Diabetes from Specialist to Primary Care: A Survey of Primary Care Physicians on the Usefulness of Tools for Transition

Using a Structured Discharge Letter Template to Improve Communication During the Transition from a Specialized Outpatient Diabetes Clinic to a Primary Care Physician

Postprandial lipaemia and vascular disease

Patient Perspectives on Discharge from Specialist Type 2 Diabetes Care Back to Primary Care: A Qualitative Study

Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors

Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function

Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood

A11518 Hemodialysis reduces levels of circulating microparticles in individuals with hypertension

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors12

Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations

PCSK9 and triglyceride-rich lipoprotein metabolism

Suchergebnisse filtern